Molecula breast imaging saved lives

Study record managers: refer to the Data Element Definitions if submitting registration or results information. A new test for breast cancer screening, molecular breast imaging MBI may be more sensitive than mammography for detecting breast cancer in women with dense breasts. The purpose of this study is to see if MBI using a low dose of gamma radiation can find cancers not seen on mammography. Hypotheses: 1. Low-Dose MBI has a significantly higher sensitivity and specificity and equal or higher positive predictive value than SM in women age 40 and older with mammographically dense breasts. Low-dose MBI has comparable sensitivity and specificity to that previously achieved with MBI using a higher dose of radiation.

Sharon Helmer, M. MBI was attractive to the Karmanos Cancer Institute because we realized that a significant number of our diagnosed cancer and high risk patients could not benefit from the functional information that Magnetic Resonance MR imaging offers. MBI looks similar to and replicates the views acquired by mammography but it does not produce X-ray radiation. Instead, MBI uses a nuclear isotope to detect tumors.

Kevin Lomangino is the managing editor of HealthNewsReview. He tweets as Klomangino. And while we wish this woman the very best in her treatment, we think NBC has an obligation to vet her claims before broadcasting them to an audience of millions. The unfortunate reality? Breast cancers vary in their aggressiveness, and some will progress and prove fatal despite early detection and treatment, whereas others grow slowly and might never pose a problem to the patient.

The mission of the Center is to discover and integrate the latest in genomic, molecular and clinical sciences into personalized care for patients. About half of screening-age women have dense breast tissue, which digital mammography renders the same whitish shade as tumors. A picture is worth a thousand words.